Search results
Results from the WOW.Com Content Network
The Genetic Information Nondiscrimination Act of 2008 (Pub. L. 110–233 (text), 122 Stat. 881, enacted May 21, 2008, GINA / ˈ dʒ iː. n ə / JEE-nə), is an Act of Congress in the United States designed to prohibit some types of genetic discrimination.
Popular choices such as tagatose and Stevia have been found to be safe for diabetics, as they don't impact the blood glucose levels in any way. Low-Fat Milk. Low-Fat Milk.
There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether you have type 2 diabetes or obesity, you may have heard ...
That being said, Ozempic is a diabetes drug meant to help people with type 2 diabetes manage their blood sugar levels. So it is designed with long-term use in mind.
Drugs used in diabetes treat diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin , most GLP-1 receptor agonists ( liraglutide , exenatide , and others), and pramlintide , all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic agents.
When diabetes is the cause, physicians typically recommend an anti-diabetic medication as treatment. From the perspective of the majority of patients, treatment with an old, well-understood diabetes drug such as metformin will be the safest, most effective, least expensive, and most comfortable route to managing the condition.
GINA may refer to: Genetic Information Nondiscrimination Act , a bill signed into United States law in 2008 designed to restrict the use of genetic information in health insurance and employment BMW GINA , a prototype car by BMW
"Health insurers would not be able to deny access, so health insurance is safe," Prince said. Protections related to other types of insurance, including long-term care and disability, are less robust.